Skip to main content
NANJING RED SUN CO., LTD logo

NANJING RED SUN CO., LTD — Investor Relations & Filings

Ticker · 000525 ISIN · CNE0000002Z5 LEI · 655600608JEK9VURCH82 Shenzhen Stock Exchange Manufacturing
Filings indexed 2,220 across all filing types
Latest filing 2024-12-12 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000525

About NANJING RED SUN CO., LTD

https://www.chinaredsun.com

Nanjing Red Sun Co., Ltd. specializes in the research, development, manufacturing, and distribution of agrochemicals and fine chemicals. The company maintains a vertically integrated industrial chain that encompasses the production of basic chemical raw materials, intermediates, and finished formulations. Its core product portfolio includes a diverse range of herbicides, insecticides, and fungicides, with a focus on high-efficiency solutions such as diquat and various pyridine-based chemicals. Red Sun emphasizes technological innovation and green manufacturing to support sustainable agricultural practices. By leveraging large-scale production capacities and advanced biochemical research, the company provides comprehensive crop protection solutions to a global customer base.

Recent filings

Filing Released Lang Actions
关于资金占用整改完成暨公司股票复牌的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from 南京红太阳股份有限公司 regarding the completion of rectification of funds occupation and the resumption of trading of the company's stock. It references regulatory actions by the Jiangsu Securities Regulatory Bureau, details about the rectification process, a special audit opinion from an accounting firm, and the stock resumption date. The document is about the completion of a regulatory-required rectification and the stock resumption, not a full financial report or audit report. It is relatively short (4261 characters) and serves as a formal announcement of the completion of a regulatory matter and stock resumption. Therefore, it fits best into the category of Regulatory Filings (RNS), as it does not contain full financial statements or detailed audit results but is a regulatory announcement about compliance and stock status.
2024-12-12 Chinese
关于业绩承诺方江苏红太阳医药集团有限公司业绩承诺补偿完成的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the completion of a performance commitment compensation by Jiangsu Hongyang Pharmaceutical Group Co., Ltd. It includes specific financial figures, court rulings, and audit reports related to the compensation and restructuring plan. The document is not a full annual or interim financial report but rather a regulatory announcement about a specific event involving performance compensation and restructuring. It contains detailed financial and legal information but does not present comprehensive financial statements or management discussion typical of annual or quarterly reports. The document also references a special audit report issued by an accounting firm but does not include the full audit report itself. Given the nature of the content, this fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2024-12-12 Chinese
关于申请撤销退市风险警示及部分其他风险警示情形暨继续被实施其他风险警示的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from a listed company regarding the application to remove delisting risk warnings and other risk warnings related to its stock trading status. It references specific regulatory rules from the Shenzhen Stock Exchange, court rulings confirming the completion of a restructuring plan, and the company's compliance with regulatory requirements. The document details the company's current risk warning status, the application to revoke certain warnings, and ongoing risk factors. It is not a full financial report, audit report, or earnings release, but rather a regulatory announcement about the company's stock risk warning status and related regulatory compliance. The document length is 3574 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit into more specific categories like delisting announcement or capital change.
2024-12-12 Chinese
*ST红阳:关于南京红太阳股份有限公司被原控股股东南京第一农药集团有限公司及其关联方占用资金清偿情况的专项说明
Audit Report / Information Classification · 95% confidence The document is a specialized audit report issued by Zhongxingcai Guanghua Certified Public Accountants LLP regarding the repayment status of funds occupied by the former controlling shareholder and its related parties of Nanjing Red Sun Co., Ltd. It includes an audit opinion on a specific fund repayment schedule for the period from January 1, 2024, to December 6, 2024. The document references auditing standards, regulatory guidelines, and provides a detailed auditor's conclusion on the fund repayment situation. It is not a full annual or interim financial report but a standalone audit report focused on a particular issue (fund occupation and repayment). The document length (8715 characters) and content indicate it is not merely an announcement or certification but a substantive audit report. Therefore, the appropriate classification is Audit Report / Information (AR).
2024-12-12 Chinese
独立董事提名人声明与承诺(魏忠雄)
Board/Management Information Classification · 95% confidence The document is a formal statement and commitment by a nominator regarding the nomination of an independent director candidate for the company's board. It includes detailed declarations about the nominee's qualifications, compliance with regulatory requirements, and independence criteria. There are no financial statements, earnings data, or report summaries. The content is focused on board/management information, specifically about a director nomination. The document length is 4254 characters, which is relatively short but contains substantive content about management nomination rather than a mere announcement or certification. Therefore, the appropriate classification is Board/Management Information (MANG).
2024-12-09 Chinese
第九届监事会第十七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolution passed at the 17th meeting of the 9th Supervisory Board of Nanjing Hongtaiyang Co., Ltd. It details the nomination and voting results for candidates to the 10th Supervisory Board. The document includes voting results and mentions that the final election requires shareholder approval at the general meeting. There is no financial data, no audit or earnings information, and no presentation or report attached. The content is about board/management changes specifically related to the supervisory board election process. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS.
2024-12-09 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.